By Sarantis Michalopoulos Est. 1min 08-10-2018 (updated: 05-11-2018 ) [Panya Studio/Shutterstock] Euractiv is part of the Trust Project >>> Print Email Facebook X LinkedIn WhatsApp Telegram In his 2017 State of the Union speech, European Commission President Jean-Claude Juncker said it was “unacceptable” that children are still dying from diseases that can easily be prevented with vaccines, like measles. In April 2018, the European Commission proposed a Council Recommendation on “Strengthened Cooperation against Vaccine-Preventable Diseases”. The EU executive notes that vaccination programmes need to adopt a life-course approach beyond childhood years. “This approach aims to ensure a lifelong adequate protection and contributes to healthy living and healthy ageing as well as the sustainability of healthcare systems,” the Commission has emphasised. In this Special Report, EURACTIV.com will examine the benefits of life-course immunisation, the roles of different stakeholders and possible ways to tackle rising anti-vaccines fake news. Download PDF Life-course vaccination – leave no one behind Video | Promoted content | Health 15-10-2018 Vaccination is unquestionably one of the most powerful and cost-effective public health measures available. Despite this, vaccination remain undervalued and underutilised, and there are numerous challenges to optimal uptake of vaccines. Recommendation on vaccines should not remain a ‘piece of paper’, Commission says News | Health 09-10-2018 Est. 5minThe European Commission’s proposed recommendation on strengthened cooperation of all stakeholders against vaccine-preventable diseases should not remain a “piece of paper” as it needs to bring tangible results for all age groups, Commission officials told EURACTIV.com. Expert: Life-course immunisation will save costs and lives Interview | Health 08-10-2018 Est. 6minThe adoption of a life-course immunisation approach in the EU will have significant multi-level effects, ranging from a healthier population to savings in healthcare budgets, Professor Daphné Holt told EURACTIV.com.
